Lombard Odier Asset Management (Switzerland)’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-259,918
| Closed | -$1.43M | – | 339 |
|
|
2022
Q1 | $1.43M | Sell |
259,918
-7,735
| -3% | -$42.6K | 0.11% | 113 |
|
|
2021
Q4 | $2.59M | Buy |
267,653
+22,640
| +9% | +$219K | 0.17% | 83 |
|
|
2021
Q3 | $4.38M | Buy |
245,013
+22,746
| +10% | +$407K | 0.27% | 79 |
|
|
2021
Q2 | $5.43M | Buy |
222,267
+58,265
| +36% | +$1.42M | 0.28% | 80 |
|
|
2021
Q1 | $4.35M | Buy |
+164,002
| New | +$4.35M | 0.29% | 77 |
|